about
Trial Watch: Proteasomal inhibitors for anticancer therapyCancer chemoprevention: current state of the artNovel and emerging targeted-based cancer therapy agents and methods.The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoTargeting Histone Deacetylases in Diseases: Where Are We?Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Design, synthesis, and preliminary bioactivity evaluation of N1 -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors.
P2860
Q28082910-7AED4A47-5962-4BA2-BF59-FE5C6EF5082FQ33783754-57CA1C25-236E-4C68-A216-BACC148BF831Q35558057-C28EA9E1-3440-4607-A4E9-2CC94B6DB23FQ35778783-813C8AC8-3918-463E-B900-307AFDF41A7EQ35821728-F587C3D9-905B-4F73-8341-21797C4A1FF3Q36893027-D38314A8-D200-4290-BA88-762E86E2C58AQ38833038-F9D6E137-2D6A-44C0-8FD6-7DF798AFEA3CQ38947405-94340929-EE1B-41A9-8A64-95C6F9A57B48Q54279170-31E6FF3E-7771-4245-8E3E-EB08958F1FFC
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Romidepsin for the treatment of T-cell lymphomas.
@ast
Romidepsin for the treatment of T-cell lymphomas.
@en
type
label
Romidepsin for the treatment of T-cell lymphomas.
@ast
Romidepsin for the treatment of T-cell lymphomas.
@en
prefLabel
Romidepsin for the treatment of T-cell lymphomas.
@ast
Romidepsin for the treatment of T-cell lymphomas.
@en
P356
P1476
Romidepsin for the treatment of T-cell lymphomas.
@en
P2093
Angie L McGraw
P304
P356
10.2146/AJHP120163
P577
2013-07-01T00:00:00Z